These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1420396)

  • 1. Primary biliary cirrhosis: current diagnosis and treatment.
    Tucker LE
    Gastroenterol Nurs; 1992 Oct; 15(2):70-6, discussion 76-7. PubMed ID: 1420396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary biliary cirrhosis: from induction to destruction.
    Nishio A; Bass NM; Luketic VA; Coppel RL; Gershwin ME
    Semin Gastrointest Dis; 2001 Apr; 12(2):89-102. PubMed ID: 11352123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary biliary cirrhosis].
    Cuković-Cavka S
    Acta Med Croatica; 2003; 57(3):221-5. PubMed ID: 14582468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary biliary cirrhosis.
    Bhandari BM; Bayat H; Rothstein KD
    Gastroenterol Clin North Am; 2011 Jun; 40(2):373-86, viii. PubMed ID: 21601785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variceal bleeding is associated with reduced risk of severe cholestasis in primary biliary cirrhosis.
    Thornton JR; Triger DR; Losowsky MS
    Q J Med; 1989 May; 71(265):467-71. PubMed ID: 2602544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
    Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
    Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary biliary cirrhosis.
    Kowdley KV; Kaplan MM
    Gastroenterologist; 1993 Sep; 1(3):199-210. PubMed ID: 8049896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary biliary cirrhosis].
    Poupon R
    Rev Prat; 1991 May; 41(13):1161-5. PubMed ID: 2063116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary biliary cirrhosis: therapy and prognosis].
    Hanada H; Okita K
    Nihon Rinsho; 1994 Jan; 52(1):256-61. PubMed ID: 8114303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
    Heathcote EJ
    Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early features of primary biliary cirrhosis: an analysis of 85 patients.
    Crowe J; Christensen E; Doniach D; Popper H; Tygstrup N; Williams R
    Am J Gastroenterol; 1985 Jun; 80(6):466-8. PubMed ID: 4003376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.
    Christensen E; Crowe J; Doniach D; Popper H; Ranek L; Rodés J; Tygstrup N; Williams R
    Gastroenterology; 1980 Feb; 78(2):236-46. PubMed ID: 7350046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
    Crippa G; Cagnoni C; Castelli A; Concesi C; Girometta S; Pancotti D; Sverzellati E; Tacchini G; Pierfranceschi MG; Carrara GC
    Clin Ter; 1995 May; 146(5):367-72. PubMed ID: 7796569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary biliary cirrhosis].
    Poupon R
    Schweiz Med Wochenschr; 1991 May; 121(20):727-32. PubMed ID: 2057739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis.
    Ono M; Sekiya C; Ohhira M; Ohhira M; Namiki M; Endo Y; Suzuki K; Matsuda Y; Taniguchi N
    J Lab Clin Med; 1991 Nov; 118(5):476-83. PubMed ID: 1682406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis.
    Harding G; McKenna R; Minuk G
    Hepatogastroenterology; 2001; 48(37):66-70. PubMed ID: 11269001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis.
    Dabaghi RE; Lester R
    Am Fam Physician; 1986 May; 33(5):155-65. PubMed ID: 3518374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.